Tagged With Coronavirus Treatment

One of Trump's COVID-19 treatments was developed using tissue that originally came from an abortion. He's tried to ban this kind of research.

Trump's physician says he has taken his first dose of remdesivir, one of the leading experimental coronavirus treatments, and is 'doing very well'

How a pillow entrepreneur got the president's ear about a dubious coronavirus 'cure'

Trump reportedly pushing new unproven coronavirus treatment that is also embraced by HUD Sec. Ben Carson and MyPillow's Mike Lindell

Inovio Pharmaceuticals sheds 12% after earnings miss, update on its COVID-19 vaccine

Pfizer, BioNTech surge after the US government orders 100 million doses of COVID-19 vaccine

UK biotech firm skyrockets 552% after drug lowers odds of serious COVID-19 symptoms

The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it's charging up to $520 a vial for remdesivir

Gilead rises after pricing its coronavirus-fighting drug remdesivir

The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients

The FDA just revoked an emergency OK for the malaria pill hydroxychloroquine in coronavirus patients, as clinical evidence piles up against the drug

The first high-quality study of malaria pill hydroxychloroquine just found it doesn't help prevent coronavirus infections

Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says

Sorrento Therapeutics skyrockets 244% after claiming a breakthrough on COVID-19 drug

New mums who've recovered from the coronavirus appear to have a 'strong immune response' to the disease in their breast milk

Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall

Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient

US health authorities are reportedly preparing to allow emergency use of Gilead's antiviral remdesivir to treat coronavirus patients, following positive study results

Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug

We're repeating one of the worst mistakes of the Ebola outbreak in the hunt for a coronavirus cure